Last reviewed · How we verify
Experimental: Primary Cohort
Experimental: Primary Cohort is a Small molecule drug developed by University of Chicago. It is currently FDA-approved. Also known as: azelastine.
At a glance
| Generic name | Experimental: Primary Cohort |
|---|---|
| Also known as | azelastine |
| Sponsor | University of Chicago |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) (PHASE1, PHASE2)
- NTLA-2002 in Adults With Hereditary Angioedema (HAE) (PHASE1, PHASE2)
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation (PHASE2)
- Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis (PHASE1, PHASE2)
- Recurrence and Anal Fistula Patient Reported Outcomes Trial
- High-Resolution CT for Heart
- A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma (PHASE1, PHASE2)
- Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Experimental: Primary Cohort CI brief — competitive landscape report
- Experimental: Primary Cohort updates RSS · CI watch RSS
- University of Chicago portfolio CI
Frequently asked questions about Experimental: Primary Cohort
What is Experimental: Primary Cohort?
Experimental: Primary Cohort is a Small molecule drug developed by University of Chicago.
Who makes Experimental: Primary Cohort?
Experimental: Primary Cohort is developed and marketed by University of Chicago (see full University of Chicago pipeline at /company/university-of-chicago).
Is Experimental: Primary Cohort also known as anything else?
Experimental: Primary Cohort is also known as azelastine.
What development phase is Experimental: Primary Cohort in?
Experimental: Primary Cohort is FDA-approved (marketed).
Related
- Manufacturer: University of Chicago — full pipeline
- Also known as: azelastine
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing